CHMP Backs Three Generics for Major Mental IllnessesCHMP Backs Three Generics for Major Mental Illnesses
The EMA committee gives green light to Duloxetine Zentiva, Aripiprazole Sandoz, and Pregabalin Accord. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 26, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news
Otsuka loses lawsuit challenging FDA approval of generic Abilify
(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify. (Source: Reuters: Health)
Source: Reuters: Health - May 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
NeuroBreak: Denial for Survival, Generic Abilify
(MedPage Today) -- News and commentary from the world of neurology and neuroscience. (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - May 5, 2015 Category: Neurology Source Type: news
Monthly News Roundup - April 2015
FDA Approves First-Time Generic for BMS’s Abilify
Abilify (aripiprazole) is a blockbuster atypical antipsychotic drug used to treat the mental illnesses schizophrenia and bipolar disorder. On April 28th, the U.S. Food and Drug Administration... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2015 Category: Pharmaceuticals Source Type: news
FDA Approves First Generic Versions of Abilify (FREE)
By the Editors
The FDA on Tuesday approved the first generic versions of the atypical antipsychotic Abilifiy (aripiprazole) for … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 30, 2015 Category: Primary Care Source Type: news
FDA grants approval for generic version of antipsychotic drug Abilify
The US Food and Drug Administration (FDA) has granted approval for the first generic versions of Abilify (aripiprazole), which is an atypical antipsychotic drug to treat schizophrenia and bipolar disorder. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 29, 2015 Category: Pharmaceuticals Source Type: news
FDA Okays First Aripiprazole GenericsFDA Okays First Aripiprazole Generics
The FDA has approved the first generic versions of the atypical antipsychotic aripiprazole. FDA Approvals (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 29, 2015 Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
FDA Approves Generic Abilify: Teva, Alembic, Hetero, Torrent Come to Market
Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 28, 2015 Category: Pharmaceuticals Source Type: news
FDA approves generic versions of antipsychotic drug Abilify
(Reuters) - The U.S. Food and Drug Administration said it approved the first copycat versions of Otsuka Pharmaceutical Co Ltd's antipsychotic drug, Abilify. (Source: Reuters: Health)
Source: Reuters: Health - April 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
FDA approves first generic Abilify to treat mental illnesses
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 28, 2015 Category: American Health Source Type: news
FDA Approves First Generic Abilify (aripiprazole) to Treat Mental Illnesses
April 28, 2015 -- The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder.
Alembic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 28, 2015 Category: Pharmaceuticals Source Type: news
aripiprazole, Abilify
Title: aripiprazole, AbilifyCategory: MedicationsCreated: 2/17/2004 12:00:00 AMLast Editorial Review: 4/13/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 13, 2015 Category: Drugs & Pharmacology Source Type: news
FDA Okays Aripiprazole for Acute Schizophrenia RelapseFDA Okays Aripiprazole for Acute Schizophrenia Relapse
The FDA has approved a labeling update for the long-acting injectable antipsychotic aripiprazole. News Alerts (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - December 9, 2014 Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
US FDA approves the labeling update of Abilify Maintena (aripiprazole) for extended-release injectable suspension to describe new clinical data for the treatment of acutely relapsed adults with schizophrenia
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - December 7, 2014 Category: Pharmaceuticals Source Type: news
Adjunctive Aripiprazole in Patients With Major DepressionAdjunctive Aripiprazole in Patients With Major Depression
Can adjunctive aripiprazole provide significant benefits in patients with major depressive disorder who showed little improvement with antidepressants? International Journal of Clinical Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 2, 2014 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news
